Your session is about to expire
← Back to Search
Behavioral Intervention
Family Support Programs for Preventing Substance Use Disorders
N/A
Recruiting
Led By Phillip W. Graham, DrPH
Research Sponsored by RTI International
Eligibility Criteria Checklist
Specific guidelines that determine who can or cannot participate in a clinical trial Must have
Must not have
Intellectual disabilities that would prohibit the completion of the SFP curriculum or data collection instruments
Timeline
Screening 3 weeks
Treatment Varies
Follow Up pre-implementation to intervention completion (ranging from 10 to 14 weeks)
Awards & highlights
No Placebo-Only Group
Summary
This trial aims to evaluate an intervention program designed to prevent the negative effects of adverse childhood experiences (ACEs) and reduce substance use and overdoses in communities facing higher rates of these issues. The study
Who is the study for?
This trial is for communities heavily impacted by substance use and adverse childhood experiences (ACEs). It aims to evaluate a program designed to prevent substance misuse and reduce the harms of ACEs. Specific eligibility criteria are not provided, suggesting that it may be open to various participants within these communities.
What is being tested?
The study compares two approaches: one group receives the Strengthening Families Program (SFP) with additional support from a Family Advocate, while another group gets only SFP. The effectiveness in preventing substance use and reducing ACEs will be measured across 36 communities.
What are the potential side effects?
Since this trial involves social interventions rather than medical treatments, traditional side effects associated with medications are not applicable. However, there could be unintended consequences or emotional impacts related to participating in such programs.
Eligibility Criteria
Exclusion Criteria
You may be eligible for the trial if you check “No” for criteria below:Select...
I can complete the SFP curriculum and all required forms.
Timeline
Screening ~ 3 weeks3 visits
Treatment ~ Varies
Follow Up ~ baseline, intervention completion (ranging from 10 to 14 weeks), and 6-month post-intervention follow-up
Screening ~ 3 weeks
Treatment ~ Varies
Follow Up ~baseline, intervention completion (ranging from 10 to 14 weeks), and 6-month post-intervention follow-up
Treatment Details
Study Objectives
Study objectives can provide a clearer picture of what you can expect from a treatment.Primary study objectives
Referrals to clinical services
Referrals to non-clinical services
Substance use perceptions of harm
+1 moreSecondary study objectives
ACEs prevalence
Average start-up cost
Cost per service referral
+4 moreOther study objectives
Lessons learned (process evaluation)
Service utilization
Social connectedness across systems (process evaluation)
+1 moreAwards & Highlights
No Placebo-Only Group
All patients enrolled in this study will receive some form of active treatment.
Trial Design
2Treatment groups
Experimental Treatment
Active Control
Group I: Strengthening Families Program + Family AdvocateExperimental Treatment1 Intervention
Families in the treatment group will be connected to clinically trained, trauma-informed FAs that will assess and refer families to community services. The intervention will provide wraparound supports to prevent ACEs and substance use and, critically, enable providers and community-based partners to align their services in a way that addresses the social determinants of health and other community-level factors that impact substance use and the relationship between social connection and ACEs. The FA component of the intervention will run concurrent to the Strengthening Families Program 7-17 sessions, with the FAs interacting weekly with families over the 10- to 14-week intervention period. On a weekly basis, FAs will conduct 1-hour, post-session check-ins with each family. This 1-hour period will consist of a 20-minute phone call with families to discuss their needs, with the remaining 40 minutes used to debrief, make service referrals, and complete documentation.
Group II: Strengthening Families Program-OnlyActive Control1 Intervention
Families in the control group will participate in the Strengthening Families Program 7-17 (SFP7-17) Group Class Curriculum for families with children ages 7-17. Parents and children participate in SFP7-17, both separately and together, as the curriculum has lessons for parents, teens, and children plus a joint Family Practice class. SFP7-17 meetings are 2 hours in length and are typically held in person (but families can participate remotely, during extenuating circumstances) with participating families completing 11 sessions over a 10- to 14-week period.
Find a Location
Who is running the clinical trial?
RTI InternationalLead Sponsor
197 Previous Clinical Trials
939,788 Total Patients Enrolled
RWJBarnabas Health Institute for Prevention and RecoveryUNKNOWN
New Jersey Prevention NetworkUNKNOWN
Phillip W. Graham, DrPHPrincipal InvestigatorRTI International
Dallas J Elgin, PhDPrincipal InvestigatorRTI International